PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 3, 2026Archives of Current Medical Research0 citations

Assessment of Dexketoprofen Trometamol on Tibia Development in Chicken Embryos

View Full Paper
MYMuhammed YıldızBGBülent GüneriKYKübra Yildiz

Key Points

  • This study aims to evaluate the effects of dexketoprofen trometamol on tibial development and growth plate structure in chicken embryos.
  • Embryos administered either saline (control) or 0.084 mg/0.1 mL DT in two phases.
  • Groups included minimum DT dose (0.042 mg), maximum DT dose (0.126 mg), double maximum dose (0.252 mg), alcohol control, and saline control.
  • Assessments included morphometric and histopathological analyses, with statistical tests like one-way ANOVA.
  • No significant differences in embryo viability at day 7 between DT and control groups.
  • Embryos receiving maximum DT dose showed increased crown-rump lengths compared to the double maximum group (p=0.015).
  • Higher growth plate proliferative zone cell counts observed in minimum and maximum dose groups versus controls.

Abstract

Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely prescribed analgesics, but their teratogenic potential remains understudied. Dexketoprofen trometamol (DT), commonly used clinically, lacks sufficient data con-cerning fetal skeletal development safety. This study investigated the effects of DT on tibial growth and growth plate structure in chicken embryos. Methods: The experiment had two phases. Initially, embryos were administered either saline solution (control) or 0.084 mg/0.1 mL DT. In the second phase, embryos were divided into five groups: minimum DT dose (0.042 mg), maximum DT dose (0.126 mg), double maximum dose (0.252 mg), alcohol control, and saline control. Eggs were incubated for seven days before morphometric and histopathological analyses. Statistical tests included Fisher's exact test, one-way ANOVA, and Kruskal–Wallis analysis.Results: In phase one, embryo viability at day 7 showed no significant difference between DT and control groups. In the second phase, embryos receiving minimum and maximum DT doses demonstrated improved developmental outcomes compared to the double maximum dose and control groups. Specifically, crown–rump lengths significantly increased in the maximum dose compared to the double maximum group (p=0.015). Tibial lengths were also superior in the maxi-mum dose group compared to saline controls. Growth plate proliferative zone cell counts were higher in minimum and maximum dose groups versus controls, notably exceeding the double maximum dose group. No significant changes appeared in tibia diameter, ossification center length, or hypertrophic zone cell counts.Conclusion: DT showed no harmful impact on chicken embryo tibial development at the adult recommended dose in viable embryos. These findings also provide insight into the potential risk of embryotoxic effects of DT, particularly at supratherapeutic exposure levels where growth-related endpoints were less favorable. However, further molecular and clinical investigations are necessary.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yıldız et al. (2026) studied this question.

synapsesocial.com/papers/6a1fc7dcdee9eb8c0dce870ehttps://doi.org/10.47482/acmr.1818300
Ask AI
Helpful
Bookmark
Share
View Full Paper